Lumen Biomedical

About:

Lumen Biomedical, Inc. develops and commercializes interventional devices for embolic protection and thrombus removal throughout the body.

Website: http://lumenbio.com

Description:

Lumen Biomedical, Inc. develops and commercializes interventional devices for embolic protection and thrombus removal throughout the body. It offers FiberNet embolic protection systems for the treatment of patients receiving endovascular intervention for carotid artery diseases; and Xtract, a thrombus aspiration catheter device that supports the care of segment elevation myocardial infarction. The company’s products are used in carotid artery procedures. It serves customers through distributors in the United States and Europe. The company was founded in 2003 and is based in Maple Grove, Minnesota.

Total Funding Amount:

$675000

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Maple Grove, Minnesota, United States

Founded Date:

2003-01-01

Contact Email:

info(AT)lumenbio.com

Founders:

Matthew Ogle

Number of Employees:

11-50

Last Funding Date:

2009-10-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai